Insider Trading History of Link William J Phd

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Link William J Phd since 2015. This trader's CIK number is 1228684. At the time of last reporting, Link William J Phd was the Director of Tarsus Pharmaceuticals, Inc.. (stock ticker symbol TARS). Also see all insider trading activities at Tarsus Pharmaceuticals, Inc..

Note that in the past LINK WILLIAM J PHD also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Edwards Lifesciences Corp (EW) by Link William J Phd

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2019 EW 0 $0 10,214 $2,267,310 0 $0
2018 EW 0 $0 25,578 $3,504,495 0 $0
2016 EW 0 $0 15,000 $1,260,135 0 $0

Yearly summary of insider trading at Oyster Point Pharma, Inc. (OYST) by Link William J Phd

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2021 OYST 0 $0 550,000 $8,174,650 0 $0
2019 OYST 27,500 $440,000 0 $0 0 $0

Yearly summary of insider trading at Glaukos Corp (GKOS) by Link William J Phd

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2020 GKOS 0 $0 50,000 $3,416,950 50,000 $1,066,100
2018 GKOS 0 $0 41,500 $2,401,063 0 $0
2016 GKOS 0 $0 64,058 $1,830,110 0 $0
2015 GKOS 0 $0 0 $0 30,037 $0

Yearly summary of insider trading at Rxsight, Inc. (RXST) by Link William J Phd

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2024 RXST 0 $0 28,250 $1,406,143 0 $0
2021 RXST 31,250 $500,000 0 $0 0 $0

Yearly summary of insider trading at Tarsus Pharmaceuticals, Inc. (TARS) by Link William J Phd

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 TARS 0 $0 0 $0 3,350 $0
2024 TARS 0 $0 35,000 $919,450 3,350 $0
2023 TARS 0 $0 0 $0 2,000 $0


Insider trading activities at 5 companies by Link William J Phd:

1. Edwards Lifesciences Corp (EW)

2. Oyster Point Pharma, Inc. (OYST)

3. Glaukos Corp (GKOS)

4. Rxsight, Inc. (RXST)

5. Tarsus Pharmaceuticals, Inc. (TARS)

Table 1. Insider trading of Edwards Lifesciences Corp (EW) by Link William J Phd

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2019-08-20 EW Sale 1,650 222.98 367,918
2019-08-21 EW Sale 8,564 221.79 1,899,392
2018-11-19 EW Sale 13,578 149.97 2,036,319
2018-02-09 EW Sale 12,000 122.35 1,468,176
2016-11-29 EW Sale 15,000 84.01 1,260,135

Table 2. Insider trading of Oyster Point Pharma, Inc. (OYST) by Link William J Phd

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2021-10-18 OYST Sale 550,000 14.86 8,174,650
2019-11-04 OYST Buy 27,500 16.00 440,000

Table 3. Insider trading of Glaukos Corp (GKOS) by Link William J Phd

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2020-12-01 GKOS Option Ex 50,000 21.32 1,066,100
2020-12-01 GKOS Sale 50,000 68.34 3,416,950
2018-11-13 GKOS Sale 14,475 58.01 839,694
2018-11-15 GKOS Sale 27,025 57.77 1,561,369
2016-11-17 GKOS Sale 30,000 33.78 1,013,400
2016-05-31 GKOS Sale 34,058 23.98 816,710
2015-06-30 GKOS Option Ex 30,037 .00 0

Table 4. Insider trading of Rxsight, Inc. (RXST) by Link William J Phd

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2024-02-01 RXST Sale 28,250 49.77 1,406,143
2021-08-03 RXST Buy 31,250 16.00 500,000

Table 5. Insider trading of Tarsus Pharmaceuticals, Inc. (TARS) by Link William J Phd

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-06-13 TARS Option Ex 3,350 .00 0
2024-08-12 TARS Sale 35,000 26.27 919,450
2024-06-24 TARS Option Ex 3,350 .00 0
2023-06-16 TARS Option Ex 2,000 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Link William J Phd (Director of Tarsus Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.